When our people share why they joined Rapport and love it here, it comes down to three things: the science, the mission, and the team. At Rapport, we’re driven by a passion for developing precision neuromedicines with the potential for fewer side effects, enabling patients and their families to enjoy healthier, more fulfilling lives. And we’re doing this with extraordinary science and awesome people (affectionately called Rapptors).
Our innovative scientific platform is centered on Receptor Associate Proteins (RAPs). RAPs are a component of neuronal receptor complexes, which play a crucial role in regulating receptor assembly and function. This precision approach has the potential to revolutionize the development of small molecule therapies. We are excited about the potential of our lead program, RAP-219. Our first indication targets focal epilepsy with additional clinical trials for neuropathic pain and bipolar disorder.
The strength of Rapport comes from our Rapptors – who are united by our mission to improve patients lives. We bring the heart and hustle to advance our science forward, always staying true to our core values. We hope you’re as excited about this opportunity as we are!
Your Impact:
The Senior Manager, Quality Assurance, will be a key member of the Quality team, leading quality assurance activities across both quality systems and GMP-focused operations to support the advancement of global Phase 3 clinical trials for RAP-219 and other assigned programs. This role will play a critical role in advancing and maturing the Quality Management System in preparation for commercialization, with a strong emphasis on GMP processes and procedures.
This position offers a unique opportunity to bridge GxP quality systems and hands-on GMP execution, supporting mission-critical activities such as batch record execution reviews while also driving continuous improvement across the broader quality framework. The ideal candidate is passionate about quality, embraces continuous improvement, and is eager to expand their QA expertise in a fast-paced, collaborative biotech environment that values learning, adaptability, and thoughtful risk-taking across various stages of clinical development. Success in this role requires comfort with ambiguity, a growth mindset, and the ability to learn from both successes and missteps while maintaining a strong commitment to quality and compliance.
Candidates may bring a strong foundation in either quality systems or GMP QA, with a demonstrated willingness to learn, grow, and develop proficiency across both areas.
Your Day-to-Day:
Must-Haves:
What makes Rapport special:
Your Compensation:
We get it. Compensation is an important part of your offer. You shouldn’t be surprised at the end of the recruiting process, and you should know that your offer is fair and equitable. How do we do this? We tell you about our hiring range now - we expect the hiring range for this role to be $165,000-185,000. Our actual offer will reflect a lot of factors including your relevant skills, experience, location, salary market data, and internal equity. In addition to a competitive salary, we also offer a pretty great benefits package. We don’t stop here - if you join Rapport, we go to the next level. We share our full salary ranges for every level across our company.
Hybrid Work Environment:
We prioritize in person connection with our fellow Rapptors! Our team members come together onsite at our Boston office on Monday, Tuesday and Wednesday to create more opportunities for innovation, collaboration, and connection.
Rapport Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
Note to Employment Agencies: Please do not forward any agency resumes. The company will not be responsible for any fees related to resumes that are unsolicited.
CCPA disclosure notice can be found here.
Rapport Therapeutics aims to transform the treatment of neurological disorders through a precision medicine approach, precisely targeting disease-driving neurocircuits by leveraging receptor-associated proteins (RAPs). With this approach, Rapport can overcome the well-established limitations of today’s neuromedicines that act indiscriminately throughout the nervous system, resulting in suboptimal efficacy and burdensome side effects. Leading the hunt for precision medicines is a team with established track records of innovation in neuroscience and drug discovery. Rapport was conceptualized and created through a partnership between Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc. (JJDC) and launched in March 2023. Rapport is based in San Diego, CA and Boston, MA. For more information, please visit www.rapportrx.com.
Take the next step in your career journey